Olodaterol in model systems of fibrosis
Franziska Herrmann(Boehringer Ingelheim (Germany))
KOPS (University of Konstanz)
January 1, 2017
Cited by 0
Related Papers
Olodaterol shows anti‐fibrotic efficacy in <i>in vitro</i> and <i>in vivo</i> models of pulmonary fibrosis
|British Journal of Pharmacology|2017|19